Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (Poliorix) in Toddlers.
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2013
At a glance
- Drugs Poliovirus vaccine inactivated (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 09 Dec 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Actual initiation date (Jun 2009) added as reported by ClinicalTrials.gov.
- 15 Aug 2009 Status changed from active, no longer recruiting to completed.